| Primary information |
|---|
| sequence ID | Seq_9082 |
| Peptide sequence | VKVLDAVRGSPAIN |
| CancerPDF_ID | CancerPDF_ID158, CancerPDF_ID8604, CancerPDF_ID10127, |
| PMID | 17269714,23667664,21805675 |
| Protein Name | Transthyretin (prealbumin),Prealbumin,Transthyretin |
| UniprotKB Entry Name | TTHY_HUMAN,TTHY_HUMAN,TTHY_HUMAN |
| Fluid | Plasma,Serum,Urine |
| M/Z | NA,1437.83,1438.8388 |
| Charge | 1,1,NA |
| Mass (in Da) | 1438.84,1439.7,NA |
| fdr | NA,NA,NA |
| Profiling Technique | MALDI-TOF,MALDI-TOF,MALDI-TOF |
| Peptide Identification technique | LC-MS/MS,FT-ICR MS/MS + nano-HPLC,MALDI-TOF-MS |
| Quantification Technique | NA,NA,NA |
| Labelled/Label Free | Label Free,Label Free,Label Free |
| FDR | NA,NA,1 |
| CancerPDF_ID | CancerPDF_ID158, CancerPDF_ID8604, CancerPDF_ID10127, |
| p-Value | NA,NA,NA |
| Software | MASCOT (v 2.1.0),MASCOT,NA |
| Length | 14,14,14 |
| Cancer Type | Normal,"Breast cancer, Lung cancer, Rectal cancer",Muscle-invasive bladder cancer |
| Database | MSDB Human Database,NA,SwissProt Database |
| Modification | NA,NA,NA |
| Number of Patients | NA,"Breast Cancer =84, lung cancer= 70, Rectal cancer = 30patients; 500 healthy",751 bladder cancer and 127 control |
| Regulation | NA,NA,Differentially expressed between cancer vs normal samples |
| Validation | NA,NA,Mann-Whitney tests and areas under receiver-operator characteristic |
| Sensitivity | NA,NA,NA |
| Specificity | NA,NA,NA |
| Accuracy | NA,NA,NA |
| Peptide Atlas | NA |
| IEDB | |